Refine Search
...discovered by Dr. John Mendelsohn at Memorial Sloan-Kettering Cancer Center in New York City and is being developed by ImClone Systems Inc., which is financing the research. Mendelsohn is now president of the University of Texas M. D. Anderson...
...Advanced Cell sold a New York biotechnology company an approximate 7 percent stake for $1 million. The deal with Imclone Systems, which includes a research collaboration, gives Advanced Cell an estimated market value of $14.3 million. ImClone...
NEW YORK (AP) -- The former chief executive of ImClone Systems was arrested by the FBI on Wednesday and charged with tipping off relatives to sell company stock a day before the FDA rejected...
...about possible insider trading, domesticity maven Martha Stewart again defended her sale of almost 4,000 shares of ImClone Systems Inc. in late December as "entirely proper and lawful." "The media focus on ImClone has generated an enormous...
...in fat paychecks that rivaled the top echelon of Hollywood elite. Many, like Enron Corp.'s CEO Kenneth Lay and ImClone Systems Inc.'s Sam Waksal, became fixtures on the privileged social circuit and in society columns. Even their homebuilding...
...asking again for the opportunity to question Stewart on her possible involvement in an insider trading scandal at ImClone Systems. The House Energy and Commerce Committee requested additional documents from Stewart on Tuesday -- including e-mails...
...And domestic design tycoon Martha Stewart faced insider trading charges for allegedly selling shares of drugmaker ImClone Systems on not-yet-public information. Corporate America's image crumbled fast. Investors were left wondering whom...
...prompting criticism that a new era of greed has tainted corporate America. Wednesday's insider-trading arrest of ImClone Systems Inc. co-founder Samuel Waksal is just the latest in a spate of scandals involving high-profile executives. It...
...security guards hustled her through a private entrance. Not one analyst asked about her sale of nearly 4,000 shares of ImClone Systems Inc., which she pulled off just before news got out in December that the Food and Drug Administration had denied...
...Investigation risk. Companies currently under scrutiny include Enron, WorldCom, Qwest, Tyco International, ImClone Systems, Global Crossing, Dynegy and Halliburton. The list is astounding. The financial and operational troubles that...